Cargando…
Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases
Galectin-3 (Gal3) is one of the most studied members of the galectin family that mediate various biological processes such as growth regulation, immune function, cancer metastasis, and apoptosis. Since Gal3 is pro-inflammatory, it is involved in many diseases that are associated with chronic inflamm...
Autores principales: | Ahmed, Rakin, Anam, Khairul, Ahmed, Hafiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179732/ https://www.ncbi.nlm.nih.gov/pubmed/37175823 http://dx.doi.org/10.3390/ijms24098116 |
Ejemplares similares
-
Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015) -
Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018) -
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
por: Nangia-Makker, Pratima, et al.
Publicado: (2022) -
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021) -
Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target
por: Boutin, Louis, et al.
Publicado: (2022)